FDA Inspection 1023366 — Precision Dose Inc.
The FDA completed an inspection of Precision Dose Inc. on May 12, 2017 in South Beloit, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 12, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- South Beloit, IL (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)